Tvardi Therapeutics (TVRD) Stock Insights

TVRD price $0.89 +0.02 +2.53%

Ticker
TVRD
Price
$0.89
Change
+0.02 +2.53%
Market cap ?
$11.83M
Beta ?
0.37
Sector
Healthcare
Industry
Biotechnology

Fair value

TVRD fair value $247.06. Price $0.89. Price is 100% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare TVRD

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-12—-0.55——
2026-08-13-0.69-0.70——
2026-05-08-0.73-0.65——
2026-03-31-0.78-0.55——
2025-11-13-0.59-0.83——
2025-08-14-1.00-0.51——
2025-05-13-3.22-0.582.57M—
2025-03-11-1.68-7.08—1.69M
2024-11-14-8.19-8.64—2.02M
2024-08-14-13.17-9.86—1.18M
2024-05-13-20.16-14.332.13M1.68M
2024-03-04-21.24-16.063.00M9.42M
2023-11-13-18.72-18.724.90M9.95M
2023-08-07-20.88-19.386.93M6.50M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-06-09Shiff Susan Ph.D.Buy6.00K$2.7816.68K
2026-06-09Smith CynthiaBuy6.00K$2.7816.68K
2026-06-09Shah SujalBuy6.00K$2.7816.68K
2026-06-09HALL WALLACE L JRBuy6.00K$2.7816.68K
2026-06-09WYZGA MICHAEL SBuy6.00K$2.7816.68K
2026-01-29O'Brien Stephen PaulBuy15.00K$3.9058.50K
2026-01-29Conn Avi DanielBuy45.00K$3.90175.50K
2026-01-29Kauh John Saewook M.D.Buy45.00K$3.90175.50K
2026-01-29Alibhai Imran NizamudinBuy115.00K$3.90448.50K
2025-12-16O'Brien Stephen PaulBuy4.00K$4.2016.80K
2025-12-16Kauh John Saewook M.D.Buy17.50K$4.2073.50K
2025-12-16Conn Avi DanielBuy17.50K$4.2073.50K
2025-12-16Alibhai Imran NizamudinBuy47.50K$4.20199.50K
2025-07-07Tweardy Samuel DavidSell315.66K——
2025-04-17Larson Jeffrey LeroyBuy10.82K$17.04184.37K
2025-04-17O'Brien Stephen PaulBuy7.21K$17.04122.91K
2025-04-17Chen YixinBuy7.21K$17.04122.91K
2025-04-17Conn Avi DanielBuy43.55K$17.04742.04K
2025-04-17Kauh John Saewook M.D.Buy36.21K$17.04617.02K
2025-04-17Alibhai Imran NizamudinBuy182.32K$17.043.11M
2025-04-17Shiff Susan Ph.D.Buy12.00K$17.04204.48K
2025-04-17Wirk ShaheenBuy12.00K$17.04204.48K
2025-04-17WYZGA MICHAEL SBuy12.00K$17.04204.48K
2025-04-17Smith CynthiaBuy12.00K$17.04204.48K
2025-04-17Shah SujalBuy12.00K$17.04204.48K
2025-04-17HALL WALLACE L JRBuy12.00K$17.04204.48K
2025-04-15HALL WALLACE L JRBuy202.04K——
2025-04-15HALL WALLACE L JRBuy44.71K——
2025-04-15Wirk ShaheenBuy263.16K——
2025-04-15Wirk ShaheenBuy176.03K——
2025-04-15Tweardy Samuel DavidOther0——
2025-04-15O'Brien Stephen PaulBuy11.40K$4.7053.58K
2025-04-15O'Brien Stephen PaulBuy3.35K$6.8622.99K
2025-04-15HALL WALLACE L JRBuy202.04K——
2025-04-15HALL WALLACE L JRBuy44.71K——
2025-04-15Kauh John Saewook M.D.Buy74.05K$6.12453.18K
2025-04-15WYZGA MICHAEL SBuy18.44K$4.7086.67K
2025-04-15Chen YixinBuy14.75K$4.7069.33K
2025-04-15Wirk ShaheenBuy263.16K——
2025-04-15Wirk ShaheenBuy176.03K——
2025-04-15Wirk ShaheenBuy4.19K——
2025-04-15Wirk ShaheenBuy2.01K$0.681.37K
2025-04-15Shah SujalBuy10.39K$0.687.07K
2025-04-15Shah SujalBuy8.05K$4.7037.82K
2025-04-15Larson Jeffrey LeroyBuy16.76K$0.6811.40K
2025-04-15Larson Jeffrey LeroyBuy5.36K$4.7025.21K
2025-04-15Conn Avi DanielBuy89.05K$4.70418.55K
2025-04-15Alibhai Imran NizamudinBuy207.88K$0.68141.36K
2025-04-15Alibhai Imran NizamudinBuy160.94K$4.70756.42K
2025-04-15Alibhai Imran NizamudinBuy2.01K$0.681.37K
2025-04-15O'Brien Stephen PaulOther0——
2025-04-15WYZGA MICHAEL SOther0——
2025-04-15HALL WALLACE L JROther0——
2025-04-15Wirk ShaheenOther0——
2025-04-15Conn Avi DanielOther0——
2025-04-15Shah SujalOther0——
2025-04-15Kauh John Saewook M.D.Other0——
2025-04-15Alibhai Imran NizamudinOther0——
2025-04-15Smith CynthiaOther0——
2025-04-15Chen YixinOther0——
2025-04-15Larson Jeffrey LeroyOther0——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 59, holders -7 vs prior quarter. Ownership 23.81%.

HolderSharesChangeChange %Value
SLATE PATH CAPITAL LP704.12K00.00%1.34M
VANGUARD CAPITAL MANAGEMENT LLC344.38K-326-0.09%654.33K
AMERICAN FINANCIAL GROUP INC223.66K00.00%424.95K
UBS GROUP AG111.13K60.68K+120.27%211.15K
SILVERCREST ASSET MANAGEMENT GROUP LLC101.03K00.00%191.97K
BLACKROCK, INC.95.48K-292.60K-75.40%181.41K
RENAISSANCE TECHNOLOGIES LLC91.41K-691-0.75%173.68K
GEODE CAPITAL MANAGEMENT, LLC90.35K-91.99K-50.45%171.74K
MORGAN STANLEY77.84K4.95K+6.79%147.91K
DUNCAN WILLIAMS ASSET MANAGEMENT, LLC63.24K00.00%120.16K
VANGUARD FIDUCIARY TRUST CO44.71K-2.16K-4.61%84.95K
RUSSELL INVESTMENTS GROUP, LTD.43.23K19.92K+85.47%82.13K
STATE STREET CORP33.90K-63.33K-65.13%64.41K
SUSQUEHANNA INTERNATIONAL GROUP, LLP33.16K33.16KNew63.01K
AQR CAPITAL MANAGEMENT LLC27.10K-15.10K-35.78%51.48K
SAVANT CAPITAL, LLC19.46K19.46KNew49.43K
NORTHERN TRUST CORP21.84K-27.25K-55.51%41.49K
GSA CAPITAL PARTNERS LLP17.89K17.89KNew34.00K
DIADEMA PARTNERS LP16.61K16.61KNew31.55K
XTX TOPCO LTD14.87K14.87KNew28.25K
BROWN ADVISORY INC11.20K11.20KNew21.28K
ARAX ADVISORY PARTNERS11.00K2.67K+32.04%20.91K
QUBE RESEARCH & TECHNOLOGIES LTD10.21K10.21KNew19.40K
PERSISTENT ASSET PARTNERS LTD4.25K4.25KNew8.08K
PNC FINANCIAL SERVICES GROUP, INC.3.52K3.00K+577.84%6.68K

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Tvardi Therapeutics (TVRD) Stock Insights

TVRD$0.89+0.02 +2.53%

$11.83M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History